Search results for Romosozumab

Romosozumab Biosimilar – Anti-SOST mAb – Research Grade, ProteoGenix, PX-TA1281

Description of Romosozumab Biosimilar - Anti-SOST mAb - Research Grade General information on Anti-SOST[Homo sapiens] (Romosozumab) Monoclonal Antibody Romosozumab is a humanized monoclonal antibody used for the treatment of osteoperosis.

Romosozumab, Kyinno, KB-1210

Romosozumab, Abbexa, abx831238

Romosozumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting SOST, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Romosozumab is a humanized monoclonal antibody indicated for the treatment of osteoperosis in postmenopausal women at high risk of fracture and patients who have failed in other treatments or are intolerant to other osteoperosis therapies9. Romosozumab prevents bone resorption and induces the formation of bone though it is associated with an increased risk of cardiac death, heart attack, and stroke in one study7, 8. In a comparison study of post menopausal women with osteoporosis and a past fracture, romosozumab for 12 months followed by alendronic acid for 12 months was superior to alendronic acid alone for 24 months3. Romosozumab also demonstrates a faster and larger increase in bone density than teriparatide4. Romosozumab is marketed in the United States by Amgen under the brand name Evinity7. Romosozumab was granted FDA approval on April 9, 2019.

Human Anti-Romosozumab Antibody (Anti-Romosozumab) ELISA Kit, Abbexa, abx392503

Human Anti-Romosozumab Antibody (Anti-Romosozumab) ELISA Kit is an ELISA Kit against Anti-Romosozumab Antibody (Anti-Romosozumab).

Romosozumab ELISA Kit, ProteoGenix, KPTX275

Description of Romosozumab ELISA Kit The Structure and Function of Romosozumab ELISA Kit Introduction Romosozumab is a monoclonal antibody that has been approved by the FDA for the treatment of osteoporosis in postmenopausal women. It works by inhibiting the activity of a protein called sclerostin, which plays a key role in the regulation of bone formation and resorption. The Romosozumab ELISA Kit is a powerful tool used by researchers to measure the levels of this antibody in various biological samples. In this article, we will delve into the structure, activity, and applications of this kit in detail. Structure of Romosozumab ELISA Kit The Romosozumab ELISA Kit is composed of several components that work together to accurately measure the levels of Romosozumab in a sample. The main components of the kit include: 1. Microplate The microplate is a 96-well plate that is coated with a specific antibody that binds to Romosozumab. This coating ensures that only Romosozumab present in the sample will be captured by the plate, while other proteins and molecules will be washed away. 2. Romosozumab Standard The Romosozumab Standard is a known concentration of Romosozumab that is included in the kit. This standard is used to create a standard curve, which is used to determine the concentration of Romosozumab in the sample. 3. Romosozumab Detection Antibody The Romosozumab Detection Antibody is a biotinylated antibody that specifically binds to Romosozumab. This antibody is used to detect the captured Romosozumab on the microplate. 4. Streptavidin-HRP Conjugate The Streptavidin-HRP Conjugate is an enzyme that binds to the biotinylated Romosozumab Detection Antibody. This enzyme catalyzes a reaction that produces a color change, which can be measured and used to determine the concentration of Romosozumab in the sample. 5. Substrate Solution The Substrate Solution is a solution that is added to the microplate after the Streptavidin-HRP Conjugate. This solution reacts with the enzyme and produces a color change that is directly proportional to the amount of Romosozumab present in the sample. Activity of Romosozumab ELISA Kit The Romosozumab ELISA Kit works on the principle of the enzyme-linked immunosorbent assay (ELISA). The microplate is first coated with a specific antibody that binds to Romosozumab. When a sample containing Romosozumab is added to the plate, the Romosozumab binds to the immobilized antibody. After washing away any unbound proteins and molecules, the Romosozumab Detection Antibody is added, followed by the Streptavidin-HRP Conjugate and Substrate Solution. The color change produced by the reaction between the enzyme and substrate is then measured using a spectrophotometer, and the Romosozumab concentration in the sample is determined using the standard curve. Applications of Romosozumab ELISA Kit The Romosozumab ELISA Kit has several applications in the field of research and drug development. Some of the key applications include: 1. Quantification of Romosozumab in Biological Samples The Romosozumab ELISA Kit is primarily used to measure the levels of Romosozumab in various biological samples, such as serum, plasma, and cell culture supernatants. This allows researchers to monitor the effectiveness of Romosozumab treatment and study its pharmacokinetics. 2. Screening of Potential Therapeutic Targets

Romosozumab ELISA Kit, Abbexa, abx395164

Romosozumab ELISA Kit is a quantitative ELISA kit for detection of Romosozumab.Romosozumab, a specific inhibitor of sclerostin, is a unique approach to therapy for postmenopausal osteoporosis and related disorders. The elucidation of sclerostin deficiency as the molecular defect of syndromes of high bone mass with normal quality, and the pivotal role of sclerostin as a mediator of osteoblastic activity and bone formation, provided the platform for the evaluation of inhibitors of sclerostin to activate bone formation.

Romosozumab Biosimilar - Research Grade, ichor.bio, ICH5108

Detects human SOST

Research Grade Romosozumab (HV185016), abinScience, HV185016